CORE VALUES

We are here to bring a brighter tomorrow to our communities and the world. With five of the most prestigious research centers in the country and an African branch working as one, we believe that by coming together as a community, we can overcome the highs and lows of Alzheimer’s disease and create hope for our tomorrow. We are passionate about making a difference, and dedicated to building a better future for those suffering from Alzheimer’s today and the generations that follow.

Trustworthy

We understand that participating in a medical research effort can be intimidating, which is why we prioritize transparency when communicating with those who decide to take part. We ensure that every individual is fully briefed on our goals, methods, potential risks, and benefits and that their privacy is carefully protected throughout the entire process.

Educational

Our primary goal is to empower those connected to Alzheimer’s with knowledge and resources that can help them better understand and cope with the effects of the disease. We believe that by encouraging people to participate in our research, we can improve the quality of life for those impacted by the disease and make advances toward developing.

Community

We recognize the importance of building a community of support among our participants. We strive to create a welcoming and inclusive environment where individuals can connect with others who are facing similar challenges, share their experiences and insights, and work.

Empowering

We are committed to empowering our participants with the knowledge, skills, and resources they need to take an active role in their own or their loved one’s care and well-being. We aspire to help individuals with Alzheimer’s disease and their families feel more informed, confident, and in control of their lives.

Building Hope For Tomorrow

About DAWN

The DAWN Alzheimer’s Research study is an international, multi-site initiative that seeks to build a resource that greatly expands Alzheimer’s disease genetic studies in the currently under represented African ancestry populations and Hispanic groups. Alzheimer’s is a complex disease with a pronounced genetic component; its estimated heritability is 60% to 80%. Though the disease can affect individuals of any ethnic and ancestral backgrounds, efforts for genetic studies have not historically been well diversified.

World Class Leadership

Our Research Team

DAWN Alzheimer’s Research takes place on sites in the USA and beyond. Below are a few notable facilities and collaborators that are a part of our study of Alzheimer’s disease in minorities. The study team includes investigators from the University of Miami, Case Western Reserve University, Columbia University, Wake Forest University, and the University of Ibadan, which is the lead institution for the African Dementia Consortium (AfDC).

University Of Miami

Margaret A. Pericak-Vance, PhD

University of Miami

Jeffery Vance, MD, PhD

University of Miami

Brian Kunkle, PhD, MPH

University of Miami

Wake Forest University

Goldie Byrd, PhD

Wake Forest University

Case Western Reserve University

Jonathan Haines, PhD

Case Western Reserve University

William Bush, PhD

Case Western Reserve University

Columbia University

Christiane Reitz, MD, PhD

Columbia University

Giuseppe Tosto, MD, PhD

Columbia University

University Of Ibadan

Rufus Akinyemi, MBBS, PhD

University of Ibadan

Adesola Ogunniyi, MBChB

University of Ibadan

Skip to content